XML 55 R46.htm IDEA: XBRL DOCUMENT
v3.23.1

ACQUISITIONS AND OTHER SIGNIFICANT TRANSACTIONS - Syngenta Seedcare agreement (Details) - USD ($) |  |  | 3 Months Ended | 9 Months Ended
--- | --- | --- | --- | ---
Oct. 06, 2022 | Sep. 12, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Mar. 31, 2022
ACQUISITIONS AND OTHER SIGNIFICANT TRANSACTIONS |  |  |  |  |  |
Revenue from contracts with customers |  |  | $ 92,984,498 | $ 68,231,084 | $ 314,376,460 | $ 226,898,734
Agreement with Syngenta Crop Protection AG |  |  |  |  |  |
ACQUISITIONS AND OTHER SIGNIFICANT TRANSACTIONS |  |  |  |  |  |
Agreement term |  | 10 years |  |  |  |
Upfront payment received | $ 50,000,000 |  |  |  |  |
Revenue from contracts with customers |  |  |  |  | 32,900,000 |
Current accruals and current deferred income including current contract liabilities |  |  | $ 17,100,000 |  | $ 17,100,000 |
Minimum profit target |  | $ 230,000,000 |  |  |  |
Rolling period to receive minimum profits |  | 2 years |  |  |  |
Syngenta's contribution to R&D investment |  | 70.00% |  |  |  |
Maximum penalty amount for breaches of the Agreement |  | $ 30,000,000 |  |  |  |
Annual reduction of penalty for breaches of the Agreement |  | $ 3,000,000 |  |  |  |
Agreement with Syngenta Crop Protection AG | Bottom of range [Member] |  |  |  |  |  |
ACQUISITIONS AND OTHER SIGNIFICANT TRANSACTIONS |  |  |  |  |  |
Royalty of gross profit Syngenta pays Bioceres (as a percent) |  | 30.00% |  |  |  |
Agreement with Syngenta Crop Protection AG | Top of range [member] |  |  |  |  |  |
ACQUISITIONS AND OTHER SIGNIFICANT TRANSACTIONS |  |  |  |  |  |
Royalty of gross profit Syngenta pays Bioceres (as a percent) |  | 50.00% |  |  |  |

X
- Definition Period of agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | biox_AgreementTerm
Namespace Prefix: | biox_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The annual reduction of the maximum amount the entity has to pay for breaches in a collaborative agreement. + References No definition available. + Details
Name: | biox_CollaborativeAgreementNonCompliancePenaltyAnnualReduction
Namespace Prefix: | biox_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The maximum amount of the entity has to pay for breaches in a collaborative agreement. + References No definition available. + Details
Name: | biox_CollaborativeAgreementNonCompliancePenaltyMaximum
Namespace Prefix: | biox_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The percentage of investment on research and development required of the counter-party in a collaborative agreement. + References No definition available. + Details
Name: | biox_CollaborativeAgreementResearchAndDevelopmentInvestmentPercentCounterParty
Namespace Prefix: | biox_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of gross profit the entity will receive on sales generated in an agreement. + References No definition available. + Details
Name: | biox_CollaborativeAgreementRoyaltyOnGrossProfit
Namespace Prefix: | biox_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The minimum amount of target profit in an agreement. + References No definition available. + Details
Name: | biox_MinimumAmountOfProfitTarget
Namespace Prefix: | biox_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The rolling period to receive the minimum profits. The failure to receive profits provides the entity to terminate the counter-party exclusivity to distribution. + References No definition available. + Details
Name: | biox_PeriodToReceiveProfitThresholdOptionToTerminate
Namespace Prefix: | biox_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of upfront payment received by the entity in an agreement. + References No definition available. + Details
Name: | biox_UpfrontAmountReceived
Namespace Prefix: | biox_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of current accruals and current deferred income including current contract liabilities. [Refer: Accruals; Deferred income including contract liabilities] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 78 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_CurrentAccrualsAndCurrentDeferredIncomeIncludingCurrentContractLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfBusinessCombinationsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2022-03-24 -Paragraph 114 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_114&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2022-03-24 -Paragraph 113 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_113_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_RevenueFromContractsWithCustomers
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | biox_IfrsCollaborativeArrangementAndArrangementOtherThanCollaborativeAxis=biox_AgreementWithSyngentaCropProtectionAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |